{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T23:44:25Z","timestamp":1786664665738,"version":"build-2736575974"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T00:00:00Z","timestamp":1677715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T00:00:00Z","timestamp":1677715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Acute Kidney Injury (AKI) in COVID-19 patients is associated with increased morbidity and mortality. In the present study, we aimed to develop a prognostic score to predict AKI development in these patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Materials and methods<\/jats:title>\n                <jats:p>This was a retrospective observational study of 2334 COVID 19 patients admitted to 23 different hospitals in Brazil, between January 10th and August 30rd, 2020. The primary outcome of AKI was defined as any increase in serum creatinine (SCr) by 0.3\u00a0mg\/dL within 48\u00a0h or a change in SCr by\u2009\u2265\u20091.5 times of baseline within 1\u00a0week, based on Kidney Disease Improving Global Outcomes (KDIGO) guidelines. All patients aged\u2009\u2265\u200918 y\/o admitted with confirmed SARS-COV-2 infection were included. Discrimination of variables was calculated by the Receiver Operator Characteristic Curve (ROC curve) utilizing area under curve. Some continuous variables were categorized through ROC curve. The cutoff points were calculated using the value with the best sensitivity and specificity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 1131 patients with COVID-19 admitted to the ICU were included. Patients mean age was 52\u2009\u00b1\u200915,8 y\/o., with a prevalence of males 60% (<jats:italic>n<\/jats:italic>\u2009=\u2009678). The risk of AKI was 33% (<jats:italic>n<\/jats:italic>\u2009=\u2009376), 78% (<jats:italic>n<\/jats:italic>\u2009=\u2009293) of which did not require dialysis. Overall mortality was 11% (<jats:italic>n<\/jats:italic>\u2009=\u2009127), while for AKI patients, mortality rate was 21% (<jats:italic>n<\/jats:italic>\u2009=\u200980). Variables selected for the logistic regression model and inclusion in the final prognostic score were the following: age, diabetes, ACEis, ARBs, chronic kidney disease and hypertension.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>AKI development in COVID 19 patients is accurately predicted by common clinical variables, allowing early interventions to attenuate the impact of AKI in these patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12882-023-03095-4","type":"journal-article","created":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T03:03:16Z","timestamp":1677726196000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Development of a Risk Score for AKI onset in COVID-19 Patients: COV-AKI Score"],"prefix":"10.1186","volume":"24","author":[{"given":"Henrique","family":"Palomba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Cubos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Bozza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando Godinho","family":"Zampieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiago Gomes","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,2]]},"reference":[{"issue":"4","key":"3095_CR1","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S2213-2600(20)30560-9","volume":"9","author":"OT Ranzani","year":"2021","unstructured":"Ranzani OT, Bastos LSL, Gelli JGM, Marchesi JF, Bai\u00e3o F, Hamacher S, et al. Characterisation of the first 250 000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data. Lancet Respir Med. 2021;9(4):407\u201318. https:\/\/doi.org\/10.1016\/S2213-2600(20)30560-9.","journal-title":"Lancet Respir Med"},{"issue":"20","key":"3095_CR2","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1001\/jama.2020.6775","volume":"323","author":"S Richardson","year":"2020","unstructured":"Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting Characteristics, Comorbidities, and Outcomes among 5700 Patients Hospitalized with COVID-19 in the New York City Area. JAMA - J Am Med Assoc. 2020;323(20):2052\u20139. https:\/\/doi.org\/10.1001\/jama.2020.6775.","journal-title":"JAMA - J Am Med Assoc"},{"issue":"23","key":"3095_CR3","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1056\/nejmra2026131","volume":"383","author":"DC Fajgenbaum","year":"2020","unstructured":"Fajgenbaum DC, June CH. Cytokine Storm. N Engl J Med. 2020;383(23):2255\u201373. https:\/\/doi.org\/10.1056\/nejmra2026131.","journal-title":"N Engl J Med"},{"issue":"1","key":"3095_CR4","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00134-020-06320","volume":"47","author":"EC Goligher","year":"2021","unstructured":"Goligher EC, Ranieri VM, Slutsky AS. Is severe COVID-19 pneumonia a typical or atypical form of ARDS? And does it matter? Intensive Care Med. 2021;47(1):83\u20135. https:\/\/doi.org\/10.1007\/s00134-020-06320.","journal-title":"Intensive Care Med"},{"issue":"1","key":"3095_CR5","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s00134-020-06294-x","volume":"47","author":"M Schmidt","year":"2021","unstructured":"Schmidt M, Hajage D, Dres M, Kimmoun A, Prevost M. Intensive Care Medicine Clinical Characteristics and Day-90 Outcomes of 4,244 critically ill adults with COVID-19: a prospective cohort study COVID-ICU group, for the REVA network and the COVID-ICU investigators*. Intensive Care Med. 2021;47(1):60\u201373. https:\/\/doi.org\/10.1007\/s00134-020-06294-x.","journal-title":"Intensive Care Med"},{"key":"3095_CR6","doi-asserted-by":"publisher","unstructured":"Argenziano MG, Bruce SL, Slater CL, et al. Characterization and clinical course of 1000 patients with COVID-19 in New York: retrospective case series. BMJ. 2020;369:1996. https:\/\/doi.org\/10.1101\/2020.04.20.20072116.","DOI":"10.1101\/2020.04.20.20072116"},{"key":"3095_CR7","doi-asserted-by":"publisher","unstructured":"Teixeira JP, Ambruso S, Griffin BR, Faubel S. Pulmonary Consequences of Acute Kidney Injury. Semin Nephrol. 2019;39(1):3\u201316. https:\/\/doi.org\/10.1016\/j.semnephrol.2018.10.001.","DOI":"10.1016\/j.semnephrol.2018.10.001"},{"issue":"7","key":"3095_CR8","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s11255-017-1585-z","volume":"49","author":"P Domenech","year":"2017","unstructured":"Domenech P, Perez T, Saldarini A, Uad P, Musso CG. Kidney\u2013lung pathophysiological crosstalk: its characteristics and importance. Int Urol Nephrol. 2017;49(7):1211\u20135. https:\/\/doi.org\/10.1007\/s11255-017-1585-z.","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"3095_CR9","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1681\/ASN.2020050615","volume":"32","author":"L Chan","year":"2021","unstructured":"Chan L, Chaudhary K, Saha A, et al. AKI in Hospitalized Patients with COVID-19. J Am Soc Nephrol. 2021;32(1):151\u201360. https:\/\/doi.org\/10.1681\/ASN.2020050615.","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"3095_CR10","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1681\/ASN.2020040509","volume":"31","author":"M Fisher","year":"2020","unstructured":"Fisher M, Neugarten J, Bellin E, Yunes M, Stahl L, Johns T, et al. AKI in Hospitalized Patients with and without COVID-19: A Comparison Study. J Am Soc Nephrol. 2020;31(9):2145\u201357. https:\/\/doi.org\/10.1681\/ASN.2020040509.","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"3095_CR11","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.3390\/jcm9082506","volume":"9","author":"I Gagliardi","year":"2020","unstructured":"Gagliardi I, Patella G, Michael A, Serra R, Provenzano M, Andreucci M. COVID-19 and the Kidney: From Epidemiology to Clinical Practice. J Clin Med. 2020;9(8):2506. https:\/\/doi.org\/10.3390\/jcm9082506.","journal-title":"J Clin Med"},{"issue":"8","key":"3095_CR12","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.ekir.2020.06.013","volume":"5","author":"SY Robbins-Juarez","year":"2020","unstructured":"Robbins-Juarez SY, Qian L, King KL, Stevens JS, Husain SA, Radhakrishnan J, et al. Outcomes for Patients With COVID-19 and Acute Kidney Injury: A Systematic Review and Meta-Analysis. Kidney Int Reports. 2020;5(8):1149\u201360. https:\/\/doi.org\/10.1016\/j.ekir.2020.06.013.","journal-title":"Kidney Int Reports"},{"key":"3095_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000509086","volume":"323","author":"J-Y Qian","year":"2020","unstructured":"Qian J-Y, Wang B, Liu B-C. Acute Kidney Injury in the 2019 Novel Coronavirus Disease. Kidney Dis. 2020;323:1\u20136. https:\/\/doi.org\/10.1159\/000509086.","journal-title":"Kidney Dis"},{"issue":"5","key":"3095_CR14","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1159\/000507305","volume":"144","author":"L Perico","year":"2020","unstructured":"Perico L, Benigni A, Remuzzi G. Should COVID-19 Concern Nephrologists? Why and to What Extent? the Emerging Impasse of Angiotensin Blockade. Nephron. 2020;144(5):213\u201321. https:\/\/doi.org\/10.1159\/000507305.","journal-title":"Nephron"},{"key":"3095_CR15","doi-asserted-by":"publisher","unstructured":"De Almeida DC, Franco MDCP, Dos Santos DRP, Santos MC, Maltoni IS, Mascotte F, et al. Acute kidney injury: Incidence, risk factors, and outcomes in severe COVID-19 patients. PLoS One. 2021;16(5):e0251048. https:\/\/doi.org\/10.1371\/journal.pone.0251048.","DOI":"10.1371\/journal.pone.0251048"},{"issue":"1","key":"3095_CR16","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.kint.2020.05.006","volume":"98","author":"JS Hirsch","year":"2020","unstructured":"Hirsch JS, Ng JH, Ross DW, Sharma P, Shah HH, Barnett RL, et al. Acute kidney injury in patients hospitalized with COVID-19. Kidney Int. 2020;98(1):209\u201318. https:\/\/doi.org\/10.1016\/j.kint.2020.05.006.","journal-title":"Kidney Int"},{"issue":"6","key":"3095_CR17","doi-asserted-by":"publisher","first-page":"100463","DOI":"10.1016\/j.xkme.2022.100463","volume":"4","author":"MC McAdams","year":"2022","unstructured":"McAdams MC, Xu P, Saleh SN, Li M, Ostrosky-Frid M, Gregg LP, et al. Risk Prediction for Acute Kidney Injury in Patients Hospitalized With COVID-19. KidneyMed. 2022;4(6):100463. https:\/\/doi.org\/10.1016\/j.xkme.2022.100463.","journal-title":"KidneyMed"},{"issue":"11","key":"3095_CR18","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/s41581-021-00452-0","volume":"17","author":"M Legrand","year":"2021","unstructured":"Legrand M, Bell S, Forni L, Joannidis M, Koyner JL, Liu K, et al. Pathophysiology of COVID-19-associated acute kidney injury. Nat Rev Nephrol. 2021;17(11):751\u201364. https:\/\/doi.org\/10.1038\/s41581-021-00452-0.","journal-title":"Nat Rev Nephrol"},{"issue":"5","key":"3095_CR19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s11886-020-01291-4","volume":"22","author":"J Simon Rico-Mesa","year":"2020","unstructured":"Simon Rico-Mesa J, White A, Anderson AS. HOT TOPIC Outcomes in Patients with COVID-19 Infection Taking ACEI\/ARB. Curr Cardiol Rep. 2020;22(5):31. https:\/\/doi.org\/10.1007\/s11886-020-01291-4.","journal-title":"Curr Cardiol Rep"},{"issue":"11","key":"3095_CR20","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s11906-020-01101","volume":"22","author":"D Patoulias","year":"2020","unstructured":"Patoulias D, Katsimardou A, Stavropoulos K, Imprialos K, Kalogirou M-S, Doumas M. Renin-Angiotensin System Inhibitors and COVID-19: a Systematic Review and Meta-Analysis. Evidence for Significant Geographical Disparities. Curr Hypertens Rep. 2020;22(11):90. https:\/\/doi.org\/10.1007\/s11906-020-01101.","journal-title":"Curr Hypertens Rep"},{"issue":"19","key":"3095_CR21","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1136\/heartjnl-2020-317336","volume":"106","author":"ME Flacco","year":"2020","unstructured":"Flacco ME, Acuti Martellucci C, Bravi F, Parruti G, Cappadona R, Mascitelli A, et al. Treatment with ACE inhibitors or ARBs and risk of severe\/lethal COVID-19: A meta-analysis. Heart. 2020;106(19):1519\u201324. https:\/\/doi.org\/10.1136\/heartjnl-2020-317336.","journal-title":"Heart"},{"issue":"9","key":"3095_CR22","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1681\/ASN.2020050699","volume":"31","author":"P Sharma","year":"2020","unstructured":"Sharma P, Uppal NN, Wanchoo R, Shah HH, Yang Y, Parikh R, et al. COVID-19\u2013Associated Kidney Injury: A Case Series of Kidney Biopsy Findings. J Am Soc Nephrol. 2020;31(9):1948\u201358. https:\/\/doi.org\/10.1681\/ASN.2020050699.","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"3095_CR23","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1007\/s40620-020-00789-y","volume":"33","author":"SS Farouk","year":"2020","unstructured":"Farouk SS, Fiaccadori E, Cravedi P, Campbell KN. COVID-19 and the kidney: what we think we know so far and what we don\u2019t. J Nephrol [Internet]. 2020;33(6):1213\u20138. https:\/\/doi.org\/10.1007\/s40620-020-00789-y.","journal-title":"J Nephrol [Internet]"},{"issue":"8","key":"3095_CR24","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1681\/ASN.2020040432","volume":"31","author":"EA Farkash","year":"2020","unstructured":"Farkash EA, Wilson AM, Jentzen JM. Ultrastructural Evidence for Direct Renal Infection with SARS-CoV-2. J Am Soc Nephrol. 2020;31(8):1683\u20137. https:\/\/doi.org\/10.1681\/ASN.2020040432.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"3095_CR25","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.kint.2020.04.003","volume":"98","author":"H Su","year":"2020","unstructured":"Su H, Yang M, Wan C, Yi LX, Tang F, Zhu HY, et al. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int. 2020;98(1):219\u201327. https:\/\/doi.org\/10.1016\/j.kint.2020.04.003.","journal-title":"Kidney Int"},{"key":"3095_CR26","doi-asserted-by":"publisher","unstructured":"Yadaw AS, Li Y-C, Bose S, Iyengar R, Bunyavanich S, Pandey G. Clinical predictors of COVID-19 mortality. medRxiv Prepr Serv Heal Sci. 2020;2020.05.19.20103036. https:\/\/doi.org\/10.1101\/2020.05.19.20103036. Preprint","DOI":"10.1101\/2020.05.19.20103036"},{"issue":"4","key":"3095_CR27","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1159\/000339789","volume":"120","author":"A Khwaja","year":"2012","unstructured":"Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron - Clin Pract. 2012;120(4):179\u201384. https:\/\/doi.org\/10.1159\/000339789.","journal-title":"Nephron - Clin Pract"},{"issue":"4","key":"3095_CR28","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.annemergmed.2020.07.022","volume":"76","author":"A Haimovich","year":"2020","unstructured":"Haimovich A, Ravindra NG, Stoytchev S, Young HP, PerryWilson F, van Dijk D, et al. Development and validation of the quick COVID-19 severity index (qCSI): a prognostic tool for early clinical decompensation. Ann EmergMed. 2020;76(4):442\u201353. https:\/\/doi.org\/10.1016\/j.annemergmed.2020.07.022.","journal-title":"Ann EmergMed"},{"issue":"1","key":"3095_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21149\/11684","volume":"63","author":"JM Mej\u00eda-Vilet","year":"2020","unstructured":"Mej\u00eda-Vilet JM, C\u00f3rdova-S\u00e1nchez BM, Fern\u00e1ndez-Camargo DA, M\u00e9ndez-P\u00e9rez RA, Morales-Buenrostro LE, Hern\u00e1ndez-Gilsoul T. A risk score to predict admission to the intensive care unit in patients with Covid-19: the ABC-GOALS score. Salud Publica Mex. 2020;63(1):1\u201311. https:\/\/doi.org\/10.21149\/11684.","journal-title":"Salud Publica Mex"},{"issue":"5","key":"3095_CR30","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1002\/jmv.26844","volume":"93","author":"IH Tanbo\u011fa","year":"2021","unstructured":"Tanbo\u011fa IH, Canpolat U, \u00c7etin EH\u00d6, Kundi H, \u00c7elik O, \u00c7a\u011flayan M, et al. Development and validation of clinical prediction model to estimate the probability of death in hospitalized patients with COVID-19: Insights from a nationwide database. J Med Virol. 2021;93(5):3015\u201322. https:\/\/doi.org\/10.1002\/jmv.26844.","journal-title":"J Med Virol"},{"issue":"1","key":"3095_CR31","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1093\/infdis\/jiaa663\/5938525","volume":"223","author":"H Sun","year":"2021","unstructured":"Sun H, Jain A, Leone MJ, Alabsi HS, Brenner LN, Ye E, et al. CoVA: An Acuity Score for Outpatient Screening that Predicts COVID-19 Prognosis. J Infect Dis. 2021;223(1):38\u201346. https:\/\/doi.org\/10.1093\/infdis\/jiaa663\/5938525.","journal-title":"J Infect Dis"},{"issue":"4","key":"3095_CR32","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/S2213-2600(20)30559-2","volume":"9","author":"RK Gupta","year":"2021","unstructured":"Gupta RK, Harrison EM, Ho A, Docherty AB, Knight SR, van Smeden M, et al. Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study. Lancet Respir Med. 2021;9(4):349\u201359. https:\/\/doi.org\/10.1016\/S2213-2600(20)30559-2.","journal-title":"Lancet Respir Med"},{"issue":"3","key":"3095_CR33","doi-asserted-by":"publisher","first-page":"e0248891","DOI":"10.1371\/journal.pone.0248891","volume":"16","author":"N Paranjape","year":"2021","unstructured":"Paranjape N, Staples LL, Stradwick CY, Ray HG, Saldanha IJ. Development and validation of a predictive model for critical illness in adult patients requiring hospitalization for COVID-19. PLoS One. 2021;16(3):e0248891. https:\/\/doi.org\/10.1371\/journal.pone.0248891.","journal-title":"PLoS One"},{"issue":"6","key":"3095_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jcla.23805","volume":"35","author":"RR Wang","year":"2021","unstructured":"Wang RR, He M, Kang Y. A risk score based on procalcitonin for predicting acute kidney injury in COVID-19 patients. J Clin Lab Anal. 2021;35(6):1\u20139. https:\/\/doi.org\/10.1002\/jcla.23805.","journal-title":"J Clin Lab Anal"},{"issue":"1","key":"3095_CR35","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s15010-021-01646-1","volume":"50","author":"JY Lu","year":"2022","unstructured":"Lu JY, Hou W, Duong TQ. Longitudinal prediction of hospital-acquired acute kidney injury in COVID-19: a two-center study. Infection. 2022;50(1):109\u201319. https:\/\/doi.org\/10.1007\/s15010-021-01646-1.","journal-title":"Infection"},{"key":"3095_CR36","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.ijid.2022.07.034","volume":"122","author":"JY Lu","year":"2022","unstructured":"Lu JY, Zhu J, Zhu J, Duong TQ. Long-short-term memory machine learning of longitudinal clinical data accurately predicts acute kidney injury onset in COVID-19: a two-center study. Int J Infect Dis. 2022;122:802\u201310. https:\/\/doi.org\/10.1016\/j.ijid.2022.07.034.","journal-title":"Int J Infect Dis"},{"issue":"1","key":"3095_CR37","doi-asserted-by":"publisher","first-page":"24439","DOI":"10.1038\/s41598-021-03894-5","volume":"11","author":"D Ponce","year":"2021","unstructured":"Ponce D, de Andrade LGM, Del GRC, Ferreiro-Fuentes A, Lombardi R. Development of a prediction score for in-hospital mortality in COVID-19 patients with acute kidney injury: a machine learning approach. Sci Rep. 2021;11(1):24439. https:\/\/doi.org\/10.1038\/s41598-021-03894-5.","journal-title":"Sci Rep"},{"issue":"8","key":"3095_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0237419","volume":"15","author":"L Jehi","year":"2020","unstructured":"Jehi L, Ji X, Milinovich A, Erzurum S, Merlino A, Gordon S, et al. Development and validation of a model for individualized prediction of hospitalization risk in 4,536 patients with COVID-19. PLoS ONE. 2020;15(8):1\u201315. https:\/\/doi.org\/10.1371\/journal.pone.0237419.","journal-title":"PLoS ONE"},{"issue":"9","key":"3095_CR39","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.2215\/CJN.00830110","volume":"5","author":"P Singh","year":"2010","unstructured":"Singh P, Rifkin DE, Blantz RC. Chronic kidney disease: An inherent risk factor for acute kidney injury? Clin J Am Soc Nephrol. 2010;5(9):1690\u20135. https:\/\/doi.org\/10.2215\/CJN.00830110.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"3095_CR40","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1152\/AJPLUNG.00189.2020","volume":"319","author":"R Sarzani","year":"2020","unstructured":"Sarzani R, Giulietti F, Di PC, Giordano P, Spannella F. Disequilibrium between the classic renin-angiotensin system and its opposing arm in SARS-CoV-2-related lung injury. Am J Physiol - Lung Cell Mol Physiol. 2020;319(2):325\u201336. https:\/\/doi.org\/10.1152\/AJPLUNG.00189.2020.","journal-title":"Am J Physiol - Lung Cell Mol Physiol"},{"key":"3095_CR41","doi-asserted-by":"publisher","unstructured":"Elena Flacco M, Acuti Martellucci C, Bravi F, Parruti G, Cappadona R, Mascitelli A, et al. Treatment with ACE inhibitors or ARBs and risk of severe\/lethal COVID-19: a meta-analysis Cardiac risk factors and prevention. Heart. 2020;0:1\u20136. https:\/\/doi.org\/10.1136\/heartjnl-2020-317336","DOI":"10.1136\/heartjnl-2020-317336"},{"issue":"1","key":"3095_CR42","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1186\/s13054-020-03195-9","volume":"24","author":"CL Onweni","year":"2020","unstructured":"Onweni CL, Zhang YS, Caulfield T, Hopkins CE, Fairweather DL, Freeman WD. ACEI\/ARB therapy in COVID-19: the double-edged sword of ACE2 and SARS-CoV-2 viral docking. Crit Care. 2020;24(1):475. https:\/\/doi.org\/10.1186\/s13054-020-03195-9.","journal-title":"Crit Care"},{"issue":"12","key":"3095_CR43","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1007\/s00134-021-06524-w","volume":"47","author":"Y Lombardi","year":"2021","unstructured":"Lombardi Y, Azoyan L, Szychowiak P, Bellamine A, Lemaitre G, Bernaux M, et al. External validation of prognostic scores for COVID-19: a multicenter cohort study of patients hospitalized in Greater Paris University Hospitals. Intensive Care Med. 2021;47(12):1426\u201339. https:\/\/doi.org\/10.1007\/s00134-021-06524-w.","journal-title":"Intensive Care Med"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-023-03095-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-023-03095-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-023-03095-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T03:04:42Z","timestamp":1677726282000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-023-03095-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,2]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3095"],"URL":"https:\/\/doi.org\/10.1186\/s12882-023-03095-4","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,2]]},"assertion":[{"value":"14 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the National Teaching and Ethical Committee (CONEP) in S\u00e3o Paulo \/ Brazil, number: 29496920.8.0000.5262 and informed consent was waived due to the observational nature of the study. The study was performed in accordance with the Declaration of Helsinki, the International Council for Harmonization and Good Clinical Practice.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed Consent to Publish \u2013 Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"46"}}